Your email has been successfully added to our mailing list.

×
0 0 0 -0.00931098696461822 0.00931098696461822 -0.00186219739292361 -0.0065176908752328 -0.00655493482309119
Stock impact report

Theratechnologies reports promising results from two peptide-drug conjugates [Seeking Alpha]

Theratechnologies Inc. - Common Shares (THTX) 
Company Research Source: Seeking Alpha
Theratechnologies (NASDAQ:THTXannouncesTH1902 (docetaxel peptide conjugate) and TH1904 (doxorubicin peptide conjugate) are more effective and better tolerated in animal models than two commonly-used ovarian cancer treatments.In vivoThe results will be presented tomorrow at the Annual Meeting of the American Association for Cancer Research. Show less Read more
Impact Snapshot
Event Time:
THTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for THTX alerts
Opt-in for
THTX alerts

from News Quantified
Opt-in for
THTX alerts

from News Quantified